CLAVIR 60MG Tablets 28s

CLAVIR

CLAVIR 60MG Tablets 28s

Daclatasvir

HILTON PHARMA (PVT) LIMITED Box 1 units

Drug Identity

Active Ingredient
Daclatasvir

What is CLAVIR?

Uses
Monjuvi is used to treat diffuse large B-cell lymphoma (DLBCL ) in combination with lenalidomide that is relapsed or refractory (r/r), or...

How to Take It

Dosage information not available for this product.

Safety Alerts

Before you receive Monjuvi, tell your healthcare provider about all of your medical conditions, including if you: have an active infection or have had one recently are pregnant or plan to become pregnant are breastfeeding or plan to breastfeed

Important Warnings

Monjuvi may cause the following serious side effects: Infusion reactions
Your healthcare provider will monitor you for infusion reactions during your infusion of Monjuvi
Tell your healthcare provider right away if you get a fever, chills, rash, flushing, headache, or shortness of breath during an infusion of Monjuvi
Low blood cell counts (platelets, red blood cells, and white blood cells)
Low blood cell counts are common with Monjuvi, but can also be serious or severe
Your healthcare provider will monitor your blood counts during treatment with Monjuvi
Tell your healthcare provider right away if you get a fever of 100
4°F (38°C) or above, or any bruising or bleeding, or fever, mouth sores, skin sores, sore throat , cough, trouble breathing

Side Effects

The most common side effects of Monjuvi when given with lenalidomide in DLBCL are: respiratory tract infection feeling tired or weak diarrhea cough fever swelling of the lower legs or hands decreased appetite infusion-related reactions. The most common side effects of Monjuvi when given with lenalidomide and rituximab in FL are: respiratory tract infections diarrhea rash feeling tired or weak muscle and bone pain constipation cough infusion-related reactions.

Drug Interactions

Other drugs may interact with Monjuvi
including prescription and over-the-counter medicines
vitamins
and herbal products . Tell your healthcare provider about all the medicines you take
including prescription and over-the-counter medicines
vitamins
and herbal supplements.

Price Intelligence

Rs 4,324.4
DVAGO observed price · as of 30 July 2026
Rs 4,324.4 per unit
DRAP approved ceiling: Rs 9,267.83 (per pack of 28)
Rs 4,324.4 per unit observed vs Rs 330.99 per unit approved — but the two are quoted for different pack sizes (retail pack vs per pack of 28), and DRAP sets a separate ceiling per pack size. Indicative only; not a compliance finding.
Reg. 084762 · approved 22 Jul, 2026
Prices across sources
DVAGORs 4,324.4
DRAPper pack of 28Rs 9,267.83

Should you consider an alternative?

Other options containing Daclatasvir, and what they are not.

For pharma professionalsCompany, market and opportunity intelligence

Company

397
brands
350
molecules
5
alerts

Prices as of 30 July 2026 · DRAP ceiling as of 30 July 2026 · schema v3-SKU

For medicine intelligence and professional reference only. Not medical advice.